Special Seminar on the Integrated Development of Clinical Pathways and Hospital Pharmacy Management and the 2025 Annual Meeting of Editorial Boards of China Pharmaceutical Affairs Successfully Held in Chongqing

At the opening ceremony, Ge Xinyong, member of the Standing Committee of the Party Committee, Vice President of Southwest University, and Chairman of the Editorial Board of China Pharmaceuticals magazine, delivered a speech. He stated that Southwest University highly values the development of journals, and in the future, the university will further integrate the high-quality resources of the School of Pharmacy and the Publishing Group. He expressed his hope to work hand-in-hand with the editorial board members and experts to develop China Pharmaceuticals into a top-tier pharmaceutical academic journal in China, contributing to the high-quality development of the pharmaceutical and healthcare industry and supporting the construction of Healthy China. Wang Li, member of the Party Committee and Deputy Director of the Chongqing Municipal Medical Products Administration, also delivered a speech, fully affirming the contributions made by China Pharmaceuticals over the past 33 years towards the high-quality development of the pharmaceutical industry. He firmly believes that, with the support of Southwest University, the development of China Pharmaceuticals will reach new heights. Zhang Fajun, Secretary of the Party Committee and Chairman of the Southwest University Publishing Group, stated that the publishing group is committed to developing China Pharmaceuticals into an academic communication platform with first-class influence and will fully support the journal in establishing a high-level academic exchange platform to serve the development of the pharmaceutical industry. Miao Jing, Director of the Brand Strategy Department of Qilu Pharmaceutical Co., Ltd., attended the opening ceremony and delivered a speech on behalf of Wu Gang, Vice General Manager. Zhang Chen, Chief Editor of the Southwest University Publishing Group, Xu Zhongren, Deputy General Manager, and Ma Jin, Editor-in-Chief of China Pharmaceuticals magazine, were invited to attend the opening ceremony. The opening ceremony was presided over by Liu Bin, Assistant Chief Editor of the Southwest University Publishing Group, Director of the Medical and Pharmaceutical Division, and Editor-in-Chief of China Pharmaceuticals magazine.

During the academic report session, Shi Luwen, Director of the International Research Center for Pharmaceutical Management at Peking University and Deputy Chairman of the Editorial Board of China Pharmaceuticals magazine; Zhao Yingbo, Director of the Pharmacy Management Research Department of the National Health Commission's Hospital Management Institute; Li Shaodong, Professor at Tsinghua University’s School of Hospital Management and former Deputy Director and First-Class Inspector of Jiangsu Provincial Health Commission; Zuo Xiaocong, Vice President of the Third Xiangya Hospital of Central South University and Deputy Chairman of the Editorial Board of China Pharmaceuticals magazine; Zhao Rongsheng, Chairman of the Labor Union of Peking University Third Hospital, Director of the Pharmacy Department, and Deputy Chairman of the Editorial Board of China Pharmaceuticals magazine; Fang Yu, Vice Dean of the School of Pharmacy at Xi’an Jiaotong University Medical College; Yan Miao, Vice President of the Second Xiangya Hospital of Central South University; Guo Jiayi, Vice President of Jinhua Hospital Affiliated to Zhejiang University School of Medicine; Zuo Hua, Chairman of the DRG Research and Practice Alliance; and Wang Qian, Director of the Pharmacy Department at the First Affiliated Hospital of Army Medical University and Associate Editor of China Pharmaceuticals magazine, delivered special reports on cutting-edge topics such as "DRG/DIP Payment Reform and High-Quality Development of Hospital Pharmacy," "Clinical Pathways and Monitoring Indicators for Hospital Pharmaceutical Management," "Clinical Pathway Management and Medical Insurance Cost Control," "Building Clinical Pathways for Precision Drug Therapy," "Implementation of Clinical Pathways and Continuous Improvement in Pharmaceutical Affairs Management," "Drug Supply Assurance under the Background of Three-Medical Synergy," "Precision Pharmaceutical Navigation in Clinical Pathways," "Hospital Clinical Pathway Management under DRG Payment System Reform," "Optimization of Clinical Pathways under the Background of DRG/DIP," and "Development and Practice of Clinical Drug Treatment Pathways." Multiple experts emphasized that, against the backdrop of ongoing reforms in medical insurance payment methods, clinical pathway management has become a crucial bridge connecting rational drug use, cost control, and healthcare quality. Hospital pharmacy needs to actively shift towards a value-oriented service model, assisting medical institutions in achieving high-quality development through precision pharmaceutical navigation and standardization of drug treatment pathways.

Liu Bin, Assistant to the Chief Editor of Southwest University Publishing Group, Director of the Medical Division, and Editor-in-Chief of "China Pharmaceutical Industry" magazine; Wang Zhuo, Director of the Pharmacy Department at the First Affiliated Hospital of Naval Medical University; Guo Cheng, Director of the Pharmacy Department at the Sixth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and Executive Editor-in-Chief of "China Pharmaceutical Industry" magazine; Chen Lin, Vice President of the Women and Children's Hospital affiliated with Chongqing Medical University; Wang Jianping, Assistant to the President of the First Affiliated Hospital of Zhejiang Chinese Medical University and Zhejiang Provincial Hospital of Traditional Chinese Medicine; Jin Ziming, Vice President of the Affiliated Hospital of Gansu University of Traditional Chinese Medicine; Zhang Xiao, Vice Dean of the School of Pharmacy at Southwest University; Zhao Quan, Director of the Pharmacy Department at Yantai Yuhuangding Hospital in Shandong Province; and Li Jinqi, Director of the Pharmacy Department at Sichuan Provincial People's Hospital, respectively hosted thematic reports.

The 2025 Annual Meeting of the Editorial Board, Youth Editorial Board, and Online Edition Editorial Board of *China Pharmaceuticals* was held concurrently. Editorial board experts and young pharmaceutical talents engaged in in-depth discussions on key topics such as improving the journal's academic quality and the development of the online edition, jointly planning a new chapter for the high-quality development of *China Pharmaceuticals*.

The editorial board of "China Pharmaceutical Industry" magazine was presided over by Professor Xia Peiyuan, chief pharmacist of the First Affiliated Hospital of Army Medical University and executive editor-in-chief of "China Pharmaceutical Industry" magazine. Liu Bin, editor-in-chief of "China Pharmaceutical Industry" magazine, delivered a work report on behalf of the editorial board. He summarized the 2025 publication work of the magazine, showcased the achievements in various fields such as premium content creation, academic activities, integrated publishing development, and health science communication, and analyzed the challenges currently faced by the journal. Looking ahead, "China Pharmaceutical Industry" magazine will fully seize the development opportunities presented by "Big Health," adhere to the service concept of "Big Pharmacy," steadily advance business expansions in journal publishing, book publishing, academic conferences, and more, and strive to build a high-level "125N" academic exchange platform.

All members of the editorial board held a lively and in-depth discussion on the future high-quality development of *China Pharmaceuticals*. Guo Cheng, Director of the Pharmacy Department at the Sixth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and Executive Editor-in-Chief of *China Pharmaceuticals*, Wen Aidong, Chief Pharmacist at the First Affiliated Hospital of Air Force Medical University and Deputy Chairman of the Editorial Board of *China Pharmaceuticals*, Liu Yao, Director of the Pharmacy Department at the Army Medical Center for Special Medicine and Associate Editor of *China Pharmaceuticals*, and Shen Aizong, Academic Director of the Pharmacy Department at the First Affiliated Hospital of the University of Science and Technology of China and Associate Editor of *China Pharmaceuticals*, delivered key speeches focusing on "how to improve the overall quality of the journal," "how to expand the journal’s influence domestically and internationally," "how to further leverage the role of the editorial board," and "how to broaden the channels for soliciting contributions." Other attending experts also actively offered suggestions, proposing numerous constructive opinions on concentrating on the forefront of the discipline, addressing industry concerns, and enhancing content quality. These inputs have provided direction and pathways for the journal to further enhance its academic standards and influence.

The online editorial board of the Youth Editorial Board of "China Pharmaceutical Industry" magazine was hosted by Zhao Ning, Deputy Chief Pharmacist of the Department of Pharmacy at Peking University First Hospital. Jin Pengfei, Director of the Department of Pharmacy at Beijing Hospital, Associate Editor of "China Pharmaceutical Industry" magazine, and Editor-in-Chief of both the Youth Editorial Board and the online version, delivered a work report on behalf of the editorial board. He systematically reviewed the significant achievements made by the editorial board in content planning, academic quality enhancement, and media integration. Furthermore, he proposed future development plans from multiple dimensions including content innovation, expansion of distribution channels, and youth talent cultivation, emphasizing the continuous strengthening of the editorial board team to further enhance the journal's academic influence.

All participating young editorial board members and online edition editors engaged in enthusiastic discussions on topics such as the functioning of young editorial board members, organization of academic activities, manuscript organization and planning, and the development of the online edition. Wei Jifu, Director of the Department of Pharmacy at Jiangsu Cancer Hospital and Associate Editor of the Youth Editorial Board of *China Pharmaceuticals*; Xu Wenfeng, Director of the Quality Inspection Office of the Department of Pharmacy at Beijing Hospital and Associate Editor of the Youth Editorial Board of *China Pharmaceuticals*; Yang Quanjun, Deputy Director of the Department of Pharmacy at the Sixth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and Associate Editor of the Youth Editorial Board of *China Pharmaceuticals*; and Qian Yan, Director of the Department of Pharmacy at the Second Affiliated Hospital of Chongqing Medical University and Deputy Editor of *China Pharmaceuticals* as well as Associate Editor of the online edition, shared their insights and practical experiences on themes such as "How to leverage the role of young editorial board members," "How to assist the journal in organizing various academic activities," "How to assist in soliciting contributions," and "How to plan and improve the online edition of the journal." Other attending representatives exchanged ideas on topics such as "the development of the Youth Editorial Board" and "special topic planning for the online edition." The young editorial board members and online edition editors actively interacted, demonstrating the vitality and responsibility of a new generation of pharmaceutical scholars.

During the conference, a certificate-awarding ceremony was held for the newly elected members of the Youth Editorial Board and the Online Edition Editorial Board. The infusion of new blood not only further optimized the structure of the editorial board but also brought new perspectives and momentum to the journal, laying a solid talent foundation for the continuous development of *China Pharmaceuticals*.

Text: Zhang Xiaolin | Images: Conference Team | Editor: Wang Yao

Re-review: Ma Jing │ Final Review: Liu Bin